ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

HBV DNA and HBsAg: Early Prediction of Response to Peginterferon alpha-2a in HBeAg-Negative Chronic Hepatitis B.

Zhang, Chong; Yang, Zhengrong; Wang, Ziyi; Dou, Xiaoguang; Sheng, Qiuju; Li, Yanwei; Han, Chao; Ding, Yang
International Journal of Medical Sciences2020DOI: 10.7150/ijms.39775
11阅读
引用收藏
分享

摘要

Objective: The proportion of hepatitis e antigen (HBeAg)-negative chronic hepatitis B (CHB) patients in China has increased rapidly. However, the response of these patients to peginterferon (peg-IFN) treatment is poor, and the antiviral treatment strategies are inconsistent. This study aimed to investigate the role of hepatitis B virus (HBV) DNA and hepatitis B surface antigen (HBsAg) in early prediction of response in HBeAg-negative CHB patients receiving peg-IFN alpha-2a. Patients and Methods: Treatment-naive HBeAg-negative patients were involved in this prospective study during 2014-2018. The HBV DNA and HBsAg were quantified at baseline and during treatment (weeks 12, 24 and 48) in sera. The factors associated with HBV DNA undetectable and HBsAg <100 IU/ml at treatment 48 weeks were assessed. Results: This study involved 45 patients. There was HBV DNA undetectable in 36 cases (80%), including 19 (52.8%) with HBsAg <100 IU/ml at week 48. The HBV DNA <2.0 log10IU/ml at week 24 (PPV = 96.9%, NPV = 66.7%, P = 0.018) was an independent predictor of HBV DNA undetectable at week 48. The HBsAg <800 IU/ml at baseline (PPV = 92.1%, NPV = 69.7%, P = 0.054) and HBsAg decline >5.00-fold at week 24 (PPV = 83.3%, NPV = 77.8%, P = 0.038) were independent predictors of HBsAg <100 IU/ml and HBV DNA undetectable at week 48. Conclusion: Early on-treatment quantification of HBV DNA and HBsAg in patients with HBeAg-negative CHB treated with peg-IFN alpha-2a may help identify those likely to be cured by this method and optimize therapy strategies.

学科与关键词

关键词
HBeAgchronic hepatitis Bprospective study
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
International Journal of Medical Sciences
发表日期
2020
卷期
第 17 卷, 第 3 期
页码
383-389
DOI
10.7150/ijms.39775
语言
ENGLISH
期刊收录
NSL.SCIE
期刊等级
3区
成果收录
PUBMED

作者

  • Z

    Zhang, Chong (第一作者)

  • Y

    Yang, Zhengrong

查看全部 8 位作者收起作者
  • W

    Wang, Ziyi

  • D

    Dou, Xiaoguang

  • S

    Sheng, Qiuju

  • L

    Li, Yanwei

  • H

    Han, Chao

  • D

    Ding, Yang

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417